The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Down‐regulation of the claudin‐18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype
Abstract
Gastric cancer (GC) is one of the most common malignancies worldwide. Genes whose expression is down‐regulated in GC may be tumour suppressor genes. In the present study, genes with decreased expression in GC were screened for by serial analysis of gene expression (SAGE) data analysis and reverse transcription (RT)‐polymerase chain reaction (PCR), and CLDN18 (encoding claudin‐18) was identified. Quantitative RT‐PCR revealed that expression of CLDN18 was down‐regulated in 13 (56.5%) of 23 GCs. Immunostaining showed that normal gastric mucosa and Paneth cells of the duodenum expressed claudin‐18 on cell membranes. Expression of claudin‐18 was reduced in several intestinal metaplasias of the stomach. Of 20 samples of gastric adenoma, 18 (90.0%) showed decreased claudin‐18 expression. Down‐regulation of claudin‐18 was observed in 84 of 146 GCs (57.5%) and correlated with poor survival in 65 advanced GCs (p = 0.0346). In addition, expression of the gastric and intestinal phenotypes of GC was examined by immunostaining for MUC5AC, MUC6, MUC2, and CD10. Of 38 GCs showing only the intestinal phenotype, down‐regulation of claudin‐18 was observed in 28 (73.7%), whereas in the remaining 108 GC cases, down‐regulation of claudin‐18 was observed in 56 (51.9%) (p = 0.0224). These results indicate that claudin‐18 is a good marker of poor survival in GC. Down‐regulation of claudin‐18 may be involved in GCs with an intestinal phenotype, and may be an early event in gastric carcinogenesis. Copyright © 2006 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Expression Profile of Gastric Carcinoma
Oue, N., Hamai, Y., Mitani, Y., Matsumura, S., Oshimo, Y., Aung, P. P., Kuraoka, K., Nakayama, H., & Yasui, W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3514 · Cited by 265
Self-citation
Cited by
Structure and function of claudins
Krause, G., Winkler, L., Mueller, S. L., Haseloff, R. F., Piontek, J., & Blasig, I. E. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.10.018 · Cited by 829
Claudin-18 Splice Variant 2 Is a Pan-Cancer Target Suitable for Therapeutic Antibody Development
Sahin, U., Koslowski, M., Dhaene, K., Usener, D., Brandenburg, G., Seitz, G., Huber, C., & Türeci, O. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1547 · Cited by 501
The claudin gene family: expression in normal and neoplastic tissues
Hewitt, K. J., Agarwal, R., & Morin, P. J. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-186 · Cited by 497
Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier
Barbara, G., Barbaro, M. R., Fuschi, D., Palombo, M., Falangone, F., Cremon, C., Marasco, G., & Stanghellini, V. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.718356 · Cited by 403
Targeting CLDN18.2 in cancers of the gastrointestinal tract: new drugs and new indications
Chen, J., Xu, Z., Hu, C., Zhang, S., Zi, M., Yuan, L., & Cheng, X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1132319 · Cited by 78
Metadata
- Authors
- Sanada, Y., Oue, N., Mitani, Y., Yoshida, K., Nakayama, H., & Yasui, W.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2006-01-24
- Volume
- 208
- Issue
- 5
- Pages
- 633-642
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2037826239
- Cited by
- 179
- References
- 1
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Down‐regulation of the claudin‐18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype. https://app.cochat.ai/papers/10.1002/path.1922
- The paper
- Sanada, Y., Oue, N., Mitani, Y., Yoshida, K., Nakayama, H., & Yasui, W. (2006). Down‐regulation of the claudin‐18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype. The Journal of Pathology. https://doi.org/10.1002/path.1922
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.